Improving quality of life through the routine use of the Patient Concerns Inventory for head and neck cancer patients: a cluster preference randomized controlled trial

Simon Rogers, Derek Lowe, Chermaine Lowies, Seow Tien Yeo, Christine Allmark, Dominic Macareavy, Gerald Michael Humphris, Robert Flavel, Cherith Semple, Stephen J Thomas, Anastasios Kanatas

Research output: Contribution to journalArticle

3 Citations (Scopus)
6 Downloads (Pure)

Abstract

Background: The consequences of treatment for Head and Neck cancer (HNC) patients has profound detrimental impacts such as impaired QOL, emotional distress, delayed recovery and frequent use of healthcare. The aim of this trial is to determine if the routine use of the Patients Concerns Inventory (PCI) package in review clinics during the first year following treatment can improve overall quality of life, reduce the social-emotional impact of cancer and reduce levels of distress. Furthermore, we aim to describe the economic costs and benefits of using the PCI. Methods: This will be a cluster preference randomised control trial with consultants either 'using' or 'not using' the PCI package at clinic. It will involve two centres Leeds and Liverpool. 416 eligible patients from at least 10 consultant clusters are required to show a clinically meaningful difference in the primary outcome. The primary outcome is the percentage of participants with less than good overall quality of life at the final oneyear clinic as measured by the University of Washington QOL questionnaire version 4 (UWQOLv4). Secondary outcomes at one-year are the mean social-emotional subscale (UWQOLv4) score, Distress Thermometer (DT) score ≥4, and key health economic measures (QALY-EQ-5D-5L; CSRI). Discussion: This trial will provide knowledge on the effectiveness of a consultation intervention package based around the PCI used at routine follow-up clinics following treatment of head and neck cancer with curative intent. If this intervention is (cost) effective for patients, the next step will be to promote wider use of this approach as standard care in clinical practice.
Original languageEnglish
Pages (from-to)444
JournalBMC Cancer
Volume18
Early online date18 Apr 2018
DOIs
Publication statusE-pub ahead of print - 18 Apr 2018

Fingerprint

Head and Neck Neoplasms
Randomized Controlled Trials
Quality of Life
Equipment and Supplies
Consultants
Economics
Thermometers
Quality-Adjusted Life Years
Cost-Benefit Analysis
Therapeutics
Referral and Consultation
Delivery of Health Care
Costs and Cost Analysis
Health
Neoplasms

Keywords

  • Head and neck Cancer
  • Patient concerns inventory
  • Quality of life
  • Patient reported outcomes
  • Intervention

Cite this

Rogers, Simon ; Lowe, Derek ; Lowies, Chermaine ; Yeo, Seow Tien ; Allmark, Christine ; Macareavy, Dominic ; Humphris, Gerald Michael ; Flavel, Robert ; Semple, Cherith ; Thomas, Stephen J ; Kanatas, Anastasios. / Improving quality of life through the routine use of the Patient Concerns Inventory for head and neck cancer patients: a cluster preference randomized controlled trial. In: BMC Cancer. 2018 ; Vol. 18. pp. 444.
@article{b4cd5c659fc5467eaf2b4e8134bca320,
title = "Improving quality of life through the routine use of the Patient Concerns Inventory for head and neck cancer patients: a cluster preference randomized controlled trial",
abstract = "Background: The consequences of treatment for Head and Neck cancer (HNC) patients has profound detrimental impacts such as impaired QOL, emotional distress, delayed recovery and frequent use of healthcare. The aim of this trial is to determine if the routine use of the Patients Concerns Inventory (PCI) package in review clinics during the first year following treatment can improve overall quality of life, reduce the social-emotional impact of cancer and reduce levels of distress. Furthermore, we aim to describe the economic costs and benefits of using the PCI. Methods: This will be a cluster preference randomised control trial with consultants either 'using' or 'not using' the PCI package at clinic. It will involve two centres Leeds and Liverpool. 416 eligible patients from at least 10 consultant clusters are required to show a clinically meaningful difference in the primary outcome. The primary outcome is the percentage of participants with less than good overall quality of life at the final oneyear clinic as measured by the University of Washington QOL questionnaire version 4 (UWQOLv4). Secondary outcomes at one-year are the mean social-emotional subscale (UWQOLv4) score, Distress Thermometer (DT) score ≥4, and key health economic measures (QALY-EQ-5D-5L; CSRI). Discussion: This trial will provide knowledge on the effectiveness of a consultation intervention package based around the PCI used at routine follow-up clinics following treatment of head and neck cancer with curative intent. If this intervention is (cost) effective for patients, the next step will be to promote wider use of this approach as standard care in clinical practice.",
keywords = "Head and neck Cancer, Patient concerns inventory, Quality of life, Patient reported outcomes, Intervention",
author = "Simon Rogers and Derek Lowe and Chermaine Lowies and Yeo, {Seow Tien} and Christine Allmark and Dominic Macareavy and Humphris, {Gerald Michael} and Robert Flavel and Cherith Semple and Thomas, {Stephen J} and Anastasios Kanatas",
year = "2018",
month = "4",
day = "18",
doi = "10.1186/s12885-018-4355-0",
language = "English",
volume = "18",
pages = "444",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",

}

Rogers, S, Lowe, D, Lowies, C, Yeo, ST, Allmark, C, Macareavy, D, Humphris, GM, Flavel, R, Semple, C, Thomas, SJ & Kanatas, A 2018, 'Improving quality of life through the routine use of the Patient Concerns Inventory for head and neck cancer patients: a cluster preference randomized controlled trial', BMC Cancer, vol. 18, pp. 444. https://doi.org/10.1186/s12885-018-4355-0

Improving quality of life through the routine use of the Patient Concerns Inventory for head and neck cancer patients: a cluster preference randomized controlled trial. / Rogers, Simon; Lowe, Derek; Lowies, Chermaine; Yeo, Seow Tien; Allmark, Christine; Macareavy, Dominic; Humphris, Gerald Michael; Flavel, Robert; Semple, Cherith; Thomas, Stephen J; Kanatas, Anastasios.

In: BMC Cancer, Vol. 18, 18.04.2018, p. 444.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Improving quality of life through the routine use of the Patient Concerns Inventory for head and neck cancer patients: a cluster preference randomized controlled trial

AU - Rogers, Simon

AU - Lowe, Derek

AU - Lowies, Chermaine

AU - Yeo, Seow Tien

AU - Allmark, Christine

AU - Macareavy, Dominic

AU - Humphris, Gerald Michael

AU - Flavel, Robert

AU - Semple, Cherith

AU - Thomas, Stephen J

AU - Kanatas, Anastasios

PY - 2018/4/18

Y1 - 2018/4/18

N2 - Background: The consequences of treatment for Head and Neck cancer (HNC) patients has profound detrimental impacts such as impaired QOL, emotional distress, delayed recovery and frequent use of healthcare. The aim of this trial is to determine if the routine use of the Patients Concerns Inventory (PCI) package in review clinics during the first year following treatment can improve overall quality of life, reduce the social-emotional impact of cancer and reduce levels of distress. Furthermore, we aim to describe the economic costs and benefits of using the PCI. Methods: This will be a cluster preference randomised control trial with consultants either 'using' or 'not using' the PCI package at clinic. It will involve two centres Leeds and Liverpool. 416 eligible patients from at least 10 consultant clusters are required to show a clinically meaningful difference in the primary outcome. The primary outcome is the percentage of participants with less than good overall quality of life at the final oneyear clinic as measured by the University of Washington QOL questionnaire version 4 (UWQOLv4). Secondary outcomes at one-year are the mean social-emotional subscale (UWQOLv4) score, Distress Thermometer (DT) score ≥4, and key health economic measures (QALY-EQ-5D-5L; CSRI). Discussion: This trial will provide knowledge on the effectiveness of a consultation intervention package based around the PCI used at routine follow-up clinics following treatment of head and neck cancer with curative intent. If this intervention is (cost) effective for patients, the next step will be to promote wider use of this approach as standard care in clinical practice.

AB - Background: The consequences of treatment for Head and Neck cancer (HNC) patients has profound detrimental impacts such as impaired QOL, emotional distress, delayed recovery and frequent use of healthcare. The aim of this trial is to determine if the routine use of the Patients Concerns Inventory (PCI) package in review clinics during the first year following treatment can improve overall quality of life, reduce the social-emotional impact of cancer and reduce levels of distress. Furthermore, we aim to describe the economic costs and benefits of using the PCI. Methods: This will be a cluster preference randomised control trial with consultants either 'using' or 'not using' the PCI package at clinic. It will involve two centres Leeds and Liverpool. 416 eligible patients from at least 10 consultant clusters are required to show a clinically meaningful difference in the primary outcome. The primary outcome is the percentage of participants with less than good overall quality of life at the final oneyear clinic as measured by the University of Washington QOL questionnaire version 4 (UWQOLv4). Secondary outcomes at one-year are the mean social-emotional subscale (UWQOLv4) score, Distress Thermometer (DT) score ≥4, and key health economic measures (QALY-EQ-5D-5L; CSRI). Discussion: This trial will provide knowledge on the effectiveness of a consultation intervention package based around the PCI used at routine follow-up clinics following treatment of head and neck cancer with curative intent. If this intervention is (cost) effective for patients, the next step will be to promote wider use of this approach as standard care in clinical practice.

KW - Head and neck Cancer

KW - Patient concerns inventory

KW - Quality of life

KW - Patient reported outcomes

KW - Intervention

U2 - 10.1186/s12885-018-4355-0

DO - 10.1186/s12885-018-4355-0

M3 - Article

VL - 18

SP - 444

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

ER -